SHERIDAN, WYOMING, USA, Sept. 15, 2022 /EINPresswire.com/ — IMARC Group provides in-depth analysis of the North American Active Pharmaceutical Ingredients industry covering market trends, investment opportunities, trends growth charts, statistics and industry outlook. The report offers comprehensive industry analysis, which includes information on market size, share, trends, analysis, growth, demand, statistics and overview. The report also includes competitor and regional analysis, as well as contemporary advancements in the global market.
North America Active Pharmaceutical Ingredients Market Overview:
The active pharmaceutical ingredients market in North America reached a value of US$72.7 billion in 2020. Looking ahead, IMARC Group expects the market to grow at a CAGR of 6.2% during the period 2021-2026. Active Pharmaceutical Ingredient (API) represents the biologically/synthetically active component of a finished pharmaceutical product. It is produced by various processes, such as recombinant DNA, fermentation, chemical synthesis, isolation, and recovery from natural sources. The API in a drug is used explicitly for the diagnosis, cure, mitigation or prevention of human health problems. It has a direct effect on the correction, restoration or modification of the physiological functions of the organism. Accordingly, API has many applications in the pharmaceutical industry regarding central nervous system disorders, diabetes, oncology, neurological diseases, cardiovascular, respiratory diseases, etc.
Download a free sample report to get a detailed overview of the report: https://www.imarcgroup.com/north-america-active-pharmaceutical-ingredients-market
North America Active Pharmaceutical Ingredients Market Trends:
Growing geriatric population and increasing prevalence of chronic diseases including cancer and diabetes are some of the major factors propelling the active pharmaceutical ingredients market in North America. Additionally, the initiation of several policies by government bodies aimed at increasing the overall healthcare expenditure of individuals is further augmenting the growth of the market. Additionally, the extensive research and development (R&D) activities carried out by major pharmaceutical manufacturers to produce higher quality APIs that have a direct effect on the safety and efficacy of the drug are also catalyzing the market in North America. North. Apart from this, growing demand for biologics that exhibit high potency and ability to treat diseases beyond the range of small molecule drugs is expected to bolster the active pharmaceutical ingredients market in North America during the forecast period.
Note: We regularly track the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.
Scope of North America Active Pharmaceutical Ingredients Market Report:
Report feature details
Base year of analysis 2020
Historical period 2015-2020
Forecast period 2021-2026
Units US$ billions
Segment Coverage Drug Type, Manufacturer Type, Synthesis Type, Therapeutic Application, Country
Key Market Segmentation:
IMARC Group provides analysis of key trends in each sub-segment of the North America Active Pharmaceutical Ingredients market report, along with growth forecast at regional and country level from 2021 to 2026. Our report has classified the market depending on the type of drug, the type of manufacturer, the type of synthesis and the therapeutic application.
Active Pharmaceutical Ingredients Market in North America
Key regions analyzed
United States
Canada
Mexico
Analysis for each country
Market by drug type
Innovative active pharmaceutical ingredients
Generic Active Pharmaceutical Ingredients
Market by Manufacturer Type
Captive manufacturers
Merchant API Manufacturers
Makers of Innovative Merchant APIs
Generic Merchant API Manufacturers
Market by Synthesis Type
Synthetic active pharmaceutical ingredients
Innovative synthetic APIs
Generic synthetic APIs
Biotech Active Pharmaceutical Ingredients
Market by drug type
Innovative biotechnology APIs
Biosimilars
Market by product type
Monoclonal antibodies
Vaccines
Cytokines
Others
Market by type of expression system
Mammalian expression system
Microbial expression system
yeast expression system
Others
Market by Therapeutic Application
Oncology
Cardiovascular and Respiratory
Diabetes
Central nervous system disorders
Neurological disorders
Others
Value chain analysis
Main drivers and challenges
Analysis of the five forces of carriers
PESTEL analysis
Government regulations
Competitive landscape
Competitive structure
Profiles of key players
Request a brochure: https://www.imarcgroup.com/request?type=report&id=1521&flag=A
Note: We are updating our reports. If you want to get the report with the latest primary and secondary data (2021-2026) including industry trends, market size and competitive landscape etc. Click on request a free sample report, the published report will be delivered to you in PDF format by e-mail within 24 to 48 hours.
Main highlights of the report:
Market Performance (2015-2020)
Market Outlook (2021-2026)
Market trends
Market drivers and success factors
Impact of COVID-19
Value chain analysis
Complete mapping of the competitive landscape
If you need specific information that is not currently covered in the report, we will provide it to you as part of the customization.
About Us:
The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.
IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.
Elena Anderson
IMARC Services Private Limited
+1 631-791-1145
write to us here
